Skip to main content
. Author manuscript; available in PMC: 2010 Sep 1.
Published in final edited form as: Pain. 2009 Jun 27;145(1-2):136–141. doi: 10.1016/j.pain.2009.05.029

Figure 1.

Figure 1

Top left: Urine output in 24h collections at baseline and 3rd day under conditions of TSD (N=15) or control sleep (N=9).

Lower left: Urinary PGE2 metabolite levels/24h urine output at baseline and 3rd day of TSD (N=15) or control sleep (N=9). Lower right: Change of log-transformed urinary PGE2 metabolite levels/24h urine output from baseline to 3rd day of TSD or control sleep. For statistical analysis, data were log-transformed due to skewed distribution. Asterisk indicate p<0.05 between groups.

B=Baseline, Day 1 to 3=Days of TSD or control sleep, R=Recovery.